ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Clinical practice guidelines"

  • Abstract Number: 1810 • ACR Convergence 2021

    Current Medication Practices and Preferences Among Patients with Psoriatic Arthritis (PsA)

    Monica Schwartzman1, Zafir Abutalib2 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2The Hospital For Special Surgery, New York, NY

    Background/Purpose: The advent of targeted synthetics and biologics has greatly broadened the options for effective treatment in PsA. Guidelines published in 2018 by the American…
  • Abstract Number: 0200 • ACR Convergence 2021

    In Undifferentiated Arthritis, DMARD-treatment Intensified During the Last Decennia but Did Not Result in Improved Outcomes

    Marloes Verstappen, Xanthe Matthijssen and Annette H.M van der Helm-van Mil, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: International guidelines stress timely DMARD-initiation in early arthritis, also when classification-criteria are not yet fulfilled. Consequently, undifferentiated arthritis (UA)-patients are increasingly treated despite placebo-controlled…
  • Abstract Number: 0096 • ACR Convergence 2020

    The Bicipital Stress Test: A Maneuver to More Accurately Diagnose Bicipital Tendinitis and Its Referred Pain Patterns

    Meredith Thomley1, David Spalding2, Ana Preda-Naumescu1 and Raymond Waldrop1, 1University of Alabama at Birmingham, Birmingham, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Inflammation of the bicipital tendon contributes heavily to shoulder joint morbidity. To date, diagnosis of bicipital tendinitis has relied on physical exam findings, particularly…
  • Abstract Number: 0145 • ACR Convergence 2020

    Treat-to-Target in Rheumatoid Arthritis: Rates of Treatment Changes in Patients Engaged with Care Management Services Compared to Historically Reported National Registry Based Estimates

    Pranav Patel1, Andrew Krueger2, Aliza Lipson3, Michele Hamburger4 and Craig Hunter5, 1CVS Health, Toledo, OH, 2Accordant Health Services, Greensboro, NC, 3Emory University, Palmetto Bay, FL, 4Frances Hamburger Institute, Hauppauge, NY, 5CVS Health, Northbrook

    Background/Purpose: Treat-to-target is the foundation of rheumatoid arthritis (RA) management. Prioritizing routine measurement of patient-reported disease activity along with conventional physician, laboratory and imaging assessments…
  • Abstract Number: 0437 • ACR Convergence 2020

    Integrating Reproductive Health in Systemic Lupus Erythematosus in a Tertiary Care Setting

    Jun Chu1, Sarthak Gupta1, Zerai Manna2, Michael Davis1, Yenealem Temesgen-Oyelakin1, Elaine Poncio1, Isabel Ochoa1, Laura Lewandowski3, Mariana Kaplan4, Alan Decherney1 and Sarfaraz Hasni2, 1National Institutes of Health, Bethesda, MD, 2Lupus Clinical Trials Unit, NIAMS/NIH, Bethesda, MD, 3NIAMS, NIH, Rockville, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Systemic Lupus Erythematosus (SLE) predominantly affects women of childbearing age. Women affected by SLE have higher risk for infertility, miscarriages, and other pregnancy complications…
  • Abstract Number: 0588 • ACR Convergence 2020

    Feast or Famine? An Institutional Assessment of Hydroxychloroquine Screening Practices

    Alanna James1, Kelli Kam1, Vaneet Sandhu2 and Christina Downey3, 1Loma Linda University Health, Loma Linda, CA, 2Loma Linda University, Loma Linda, CA, 3Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Hydroxychloroquine (HCQ) is a generally safe and widely used rheumatologic drug. Maculopathy is an adverse effect in < 1% in the first 5 years…
  • Abstract Number: 0620 • ACR Convergence 2020

    Do Physical Therapists Follow Evidence-Based Practice Recommendations for Treatment of Inflammatory Arthritides?

    Debbie Ehrmann Feldman1, Tatiana Orozco1, Sasha Bernatsky2, François Desmeules1, Maude Laliberté3, Kadija Perreault4, Jonathan El-Khoury5, Jean Légaré4 and Linda Woodhouse6, 1Université de Montréal, Montreal, QC, Canada, 2The Research Institute of the McGill University Health Centre, Montreal, ON, Canada, 3Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Canada, 4Université Laval, Québec, QC, Canada, 5Université de Sherbrooke, Montreal, QC, Canada, 6Curtin University, Perth, Australia

    Background/Purpose: Physical therapy plays an important role in the global management of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Therapeutic exercises (mobility, strength and aerobic)…
  • Abstract Number: 0667 • ACR Convergence 2020

    Gout Management Beyond Prescription Writing: The Role of the Pharmacist

    Emma Dorris1, Paul Ryan2, Mariosa Kieran3, Nicola Dalbeth4 and Geraldine McCarthy5, 1School of Medicine, Dublin, Dublin, Ireland, 2Mayfield Family Practice, Cork, Cork, Ireland, 3Pharmacy Department, Dublin, Dublin, Ireland, 4University of Auckland, Auckland, New Zealand, 5University College Dublin, Dublin, Dublin, Ireland

    Background/Purpose: Urate lowering therapy (ULT) is recommended for long-term gout management. However, gout flares are common at the time of starting ULT, and these flares…
  • Abstract Number: 0676 • ACR Convergence 2020

    Surveying Practicing Rheumatologists Regarding Gout Management and Barriers in Gout Care

    Joshua Gavin1, Yashswee KC2, Evan Dombrosky3, Nehal Shah4 and Youssef Roman4, 1Virginia Commonwealth University School of Medicine, Richmond, 2Virginia Commonwealth University School of Medicine, Henrico, VA, 3Virginia Commonwealth University School of Medicine, Glen Allen, VA, 4Virginia Commonwealth University School of Medicine, Richmond, VA

    Background/Purpose: The management of gout is heterogeneous across specialties and clinical settings. Gout has been demonstrated to be one of the most poorly managed conditions…
  • Abstract Number: 0879 • ACR Convergence 2020

    Application of Treat-to-Target in Axial Spondyloarthritis in Daily Practice

    Esther Beckers1, Annelies Boonen1, Casper Webers1, Peter Ten Klooster2, Harald Vonkeman2, Monique Efde3 and Astrid van Tubergen4, 1Maastricht University Medical Center, Maastricht, Netherlands, 2University of Twente, Enschede, Netherlands, 3VieCuri Medical Center, Venlo, Netherlands, 4Maastricht University Medical Center, Maastricht

    Background/Purpose: Treat-to-target (T2T) management strategies in inflammatory rheumatic diseases aim to prevent damage and improve overall functioning and health by treating patients towards a predefined…
  • Abstract Number: 1148 • ACR Convergence 2020

    The SHARE Recommendations on Diagnosis and Treatment of Systemic JIA

    Arjen Leek1, Jordi Anton2, Tadej Avcin3, Fabrizio De Benedetti4, Victor Boom1, Claudia Bracaglia5, Paul Brogan6, Tamas Constantin7, Alessandro Consolaro8, Pavla Dolezalova9, Despina Eleftheriou10, Helen Foster11, Claas Hinze12, Isabelle Koné-Paut13, Kirsten Minden14, Francesca Minoia15, Pierre Quartier16, Angelo Ravelli8, Nicolino Ruperto17, Joost Swart18, Yosef Uziel19, Helmut Wittkowski20, Carine Wouters21, Mojca Zajc Avramovitz22, Nico Wulffraat18 and Sebastiaan Vastert1, 1University Medical Center Utrecht, Utrecht, Netherlands, 2Sant Joan de Déu Hospital, Madrid, Spain, 3Ljubljana University Medical Centre, Ljubljana, Slovenia, 4Division of Rheumatology, Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 5Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 6UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 7Semmelweiss University Hospital, Budapest, Hungary, 8Università degli Studi di Genova, Genoa, Italy, 9University Hospital Prague, Prague, Czech Republic, 10UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, Section Head Infection, Immunology, and Rheumatology, London, United Kingdom, 11Newcastle University, Newcastle upon Tyne, United Kingdom, 12University Hospital M�nster, M�nster, Germany, 13Necker Hospital, Paris, France, 14Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 15Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 16Necker-Enfants Malades University Hospital, Assistance Publique-Hopitaux de Paris, Paris, France, 17Istituto Giannina Gaslini, Genova, Italy, 18IRCCS Istituto Giannina Gaslini, PRINTO, Genoa, Italy, Genova, Italy, 19Meir Medical Center, Kfar Saba, Israel, 20University Hospital Muenster, Muenster, Germany, 21University Hospital Leuven, Leuven, Belgium, 22University Hospital Ljubljana, Ljubljana, Slovenia

    Background/Purpose: Systemic juvenile idiopathic arthritis (sJIA) is a rare, complex auto-inflammatory disease with significant morbidity including fever, rash, serositis and articular problems. With the availability…
  • Abstract Number: 1172 • ACR Convergence 2020

    Cardiovascular involvement as a clue for diagnosis of Juvenile Systemic Sclerosis sine scleroderma

    Gloria Lanzoni1, Giorgia Martini1, Alessandra Meneghel1, Fabio Vittadello2, Biagio Castaldi1, Elisabetta Zanatta3 and Francesco Zulian1, 1Department of Woman's and Child's Health, University of Padova, Padua, Italy, 2Centro Studi Statistici Explora, Padua, Italy, 3Department of Medicine-DIMED, University of Padova, Padua, Italy

    Background/Purpose: Juvenile Systemic Sclerosis (JSSc) is a rare condition in childhood and its variety with no skin involvement, systemic sclerosis sine scleroderma (JSSSS) is anecdotal…
  • Abstract Number: 1481 • ACR Convergence 2020

    A Systematic Review to Quantify the Extent of Pharmaceutical Company Involvement in Rheumatology Consensus-Based Recommendations

    Dominique Feterman Jimenez1, Garret Duron2, Ali Duarte-Garcia3, Paul Sufka4, Samuel Whittle5, Philip Robinson6, Larry Prokop3 and Michael Putman7, 1UConn Health Center, Farmington, CT, 2HCA Memorial Health University Medical Center, Savannah, GA, 3Mayo Clinic, Rochester, MN, 4Healthpartners, St Paul, 5Rheumatology Unit, The Queen Elizabeth Hospital, Springfield, South Australia, Australia, 6University of Queensland, Herston, Queensland, Australia, 7Northwestern University, Chicago, IL

    Background/Purpose: Consensus-based recommendations guide standards of care for clinical practice. Pharmaceutical-industry involvement in producing such recommendations may undermine their objectivity. We performed a systematic review…
  • Abstract Number: 1590 • ACR Convergence 2020

    Bone Health in ANCA – Associated Vasculitis Patients

    Deepa Ragesh Panikkath1, Sandy Lee2 and Christina Downey2, 1Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, 2Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Glucocorticoids (GC) are an important mode of therapy in ANCA associated vasculitis (AAV), and osteoporosis (OP) and fractures are potential adverse effects seen. The…
  • Abstract Number: 1623 • ACR Convergence 2020

    Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol

    Elena Joerns1, Bonnie Bermas2, Puneet Bajaj3, Nagendra Pokala1, Reuben Arasaratnam4, Joan Reisch1 and Dan (Clarie) Wang1, 1University of Texas Southwestern Medical Center, Dallas, TX, 2UTSouthwestern.edu, Dallas, TX, 3UT Southwestern, Dallas, TX, 4UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Rheumatology patients are particularly vulnerable to pneumococcal infection due to both their underlying disease and immunosuppressive therapy. Thus, quality improvement metrics include increasing pneumococcal…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology